Cargando…
Recent Advances in Oral Peptide or Protein-Based Drug Liposomes
The high physiology and low toxicity of therapeutic peptides and proteins have made them a hot spot for drug development in recent years. However, their poor oral bioavailability and unstable metabolism make their clinical application difficult. The bilayer membrane of liposomes provides protection...
Autores principales: | Cui, Jian, Wen, Zhiwei, Zhang, Wei, Wu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501131/ https://www.ncbi.nlm.nih.gov/pubmed/36145293 http://dx.doi.org/10.3390/ph15091072 |
Ejemplares similares
-
Adapting liposomes for oral drug delivery
por: He, Haisheng, et al.
Publicado: (2019) -
Recent Advances in Liposome-Based Molecular Robots
por: Shoji, Kan, et al.
Publicado: (2020) -
Elastic liposomes as novel carriers: recent advances in drug delivery
por: Hussain, Afzal, et al.
Publicado: (2017) -
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
por: Duong, Van-An, et al.
Publicado: (2023) -
Recent Advances in Liposomal-Based Anti-Inflammatory Therapy
por: van Alem, Carla M. A., et al.
Publicado: (2021)